ImmuSmol stands for “immunoglobulins [antibodies] against small molecules”. While traditional antibodies only recognize large molecules such as proteins, ImmuSmol designs and develops antibodies capable of targeting low molecular weight entities (<900 Da).
Amino acids, lipids, saccharids, toxins, drugs, … virtually any small molecule can thus be addressed with high affinity and specificity. Fully compatible with existing antibody-based technologies, small molecule antibodies are opening a whole new set of possibilities in research, diagnostics and therapy.
Target class: |
DBA-ITALIA Srl
Via Umbria 10
20090 Segrate (Milano)
Tel. +39 02-26922300
Fax +39 02-26926058
Fax +39 02-26923535